Recro Pharma Inc (REPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

490 LAPP ROAD MALVERN, PA 19355

Recro Pharma, Inc is a specialty pharmaceutical company. The company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Recro Pharma offers its products to the medical industry.

Data based on most recent fiscal year report
Market Cap204.117 Million Shares Outstanding19.13 Million Avg Volume217.351 Thousand
1-Yr BETA vs S&P TR0.752 Current Ratio1.75 Quick Ratio1.55
View SEC Filings from REPH instead.
Q1 2019 All Institutions Hedge Funds 1
To trade REPH now:
Filers who had this stock in their top 10: 1 1 (0.1%)
13F Filers holding this stock: 73 15 (1.53%)
Aggregate 13F shares on 03/31/2019: 12.64 Million 6.971 Million
Aggregate 13F shares on 12/31/2018: 12.169 Million 7.417 Million
Percent change: 3.87% -6.02%
Funds creating new positions: 9 2
Funds Adding to an existing position: 30 5
Funds closing out their position: 4 3
Funds reducing their position: 23 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding REPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

40 Thousand total shares from 1 transactions

Open Market Sells (S)

144.8 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

123.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CELANO MICHAEL DIRECTOR

62,642 2019-05-21 3

AJDLER ARNAUD

  • Director
1,112,501 2019-05-17 4

ALTOMARI ALFRED

  • Director
32,841 2019-05-15 1

CHURCHILL WINSTON J

  • Director
24,207 2019-05-15 1

HENWOOD GERALDINE PRESIDENT AND CEO

  • Officer
  • Director
248,141 2019-05-13 6

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • Director
4,281,943 2019-05-10 0

BERELOWITZ MICHAEL

  • Director
27,412 2019-05-09 1

ASHTON WILLIAM

  • Director
27,412 2019-05-09 1

WEISMAN WAYNE

  • Director
34,412 2019-05-09 1

FLYNN KAREN

  • Director
28,212 2019-05-09 1

REASONS BRYAN M.

  • Director
22,987 2019-05-09 1

LAKE RYAN DAVID CHIEF FINANCIAL OFFICER

  • Officer
29,748 2019-01-18 5

LUDOMIRSKI ABRAHAM

  • Director
103,346 2019-01-02 0

MATTILA JYRKI

  • Director
0 2018-03-15 0

MYERS DIANE SENIOR VP-REG/QUALITY

  • Officer
18,528 2018-01-18 0

MACK RANDALL SENIOR VP, DEVELOPMENT

  • Officer
33,752 2018-01-18 0

MCCALLUM STEWART CHIEF MEDICAL OFFICER

  • Officer
31,841 2018-01-18 0

GRAFF FRED CHIEF COMMERCIAL OFFICER

  • Officer
27,083 2018-01-18 0

SCP VITALIFE PARTNERS (ISRAEL) II, L.P.

  • 10% Owner
726,055 2018-01-04 0

SCP VITALIFE PARTNERS II LP

  • 10% Owner
2,172,900 2018-01-04 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2017-06-12 0

STONEPINE CAPITAL MANAGEMENT, LLC

  • 10% Owner
No longer subject to file 2017-05-12 0

NICHOLS DONNA CAO/CONTROLLER

  • Officer
0 2017-01-18 0

GARNER CHARLES CFO AND CHIEF BUSINESS OFFICER

  • Officer
5,000 2015-06-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AJDLER ARNAUD - Director see footnote

2019-05-17 P 40,000 $9.00 a 1,104,546 1,112,501.00 indirect

HENWOOD GERALDINE - Director - Officer PRESIDENT AND CEO

2019-05-13 M 123,500 d 0 248,141.00 direct

HENWOOD GERALDINE - Director - Officer PRESIDENT AND CEO

2019-05-13 M 123,500 $2.47 a 342,947 248,141.00 direct

HENWOOD GERALDINE - Director - Officer PRESIDENT AND CEO

2019-05-13 S 21,306 $8.89 d 198,141 248,141.00 direct yes

HENWOOD GERALDINE - Director - Officer PRESIDENT AND CEO

2019-05-13 S 123,500 $8.89 d 219,447 248,141.00 direct yes

REASONS BRYAN M. - Director

2019-05-09 A 10,888 a 10,888 22,987.00 direct

AJDLER ARNAUD - Director

2019-05-09 A 7,955 a 7,955 1,072,501.00 direct

WEISMAN WAYNE - Director

2019-05-09 A 10,888 a 10,888 34,412.00 direct

CHURCHILL WINSTON J - Director

2019-05-09 A 7,955 a 27,412 27,412.00 direct

ALTOMARI ALFRED - Director

2019-05-09 A 10,888 a 10,888 28,912.00 direct

FLYNN KAREN - Director

2019-05-09 A 10,888 a 10,888 28,212.00 direct

REASONS BRYAN M. - Director

2019-05-09 A 7,955 a 22,987 22,987.00 direct

BERELOWITZ MICHAEL - Director

2019-05-09 A 10,888 a 10,888 27,412.00 direct

WEISMAN WAYNE - Director

2019-05-09 A 7,955 a 34,412 34,412.00 direct

ASHTON WILLIAM - Director

2019-05-09 A 10,888 a 10,888 27,412.00 direct

ALTOMARI ALFRED - Director

2019-05-09 A 7,955 a 28,912 28,912.00 direct

FLYNN KAREN - Director

2019-05-09 A 7,955 a 28,212 28,212.00 direct

AJDLER ARNAUD - Director

2019-05-09 A 10,888 a 10,888 1,072,501.00 direct

BERELOWITZ MICHAEL - Director

2019-05-09 A 7,955 a 27,412 27,412.00 direct

CHURCHILL WINSTON J - Director

2019-05-09 A 10,888 a 10,888 27,412.00 direct

ASHTON WILLIAM - Director

2019-05-09 A 7,955 a 27,412 27,412.00 direct

AJDLER ARNAUD - Director

2019-03-25 A 20,000 a 20,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments